A replication study of JTC bias, genetic liability for psychosis and delusional ideation.


Journal

Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142

Informations de publication

Date de publication:
07 2022
Historique:
pubmed: 14 10 2020
medline: 16 7 2022
entrez: 13 10 2020
Statut: ppublish

Résumé

This study attempted to replicate whether a bias in probabilistic reasoning, or 'jumping to conclusions'(JTC) bias is associated with being a sibling of a patient with schizophrenia spectrum disorder; and if so, whether this association is contingent on subthreshold delusional ideation. Data were derived from the EUGEI project, a 25-centre, 15-country effort to study psychosis spectrum disorder. The current analyses included 1261 patients with schizophrenia spectrum disorder, 1282 siblings of patients and 1525 healthy comparison subjects, recruited in Spain (five centres), Turkey (three centres) and Serbia (one centre). The beads task was used to assess JTC bias. Lifetime experience of delusional ideation and hallucinatory experiences was assessed using the Community Assessment of Psychic Experiences. General cognitive abilities were taken into account in the analyses. JTC bias was positively associated not only with patient status but also with sibling status [adjusted relative risk (aRR) ratio : 4.23 CI 95% 3.46-5.17 for siblings and aRR: 5.07 CI 95% 4.13-6.23 for patients]. The association between JTC bias and sibling status was stronger in those with higher levels of delusional ideation (aRR interaction in siblings: 3.77 CI 95% 1.67-8.51, and in patients: 2.15 CI 95% 0.94-4.92). The association between JTC bias and sibling status was not stronger in those with higher levels of hallucinatory experiences. These findings replicate earlier findings that JTC bias is associated with familial liability for psychosis and that this is contingent on the degree of delusional ideation but not hallucinations.

Sections du résumé

BACKGROUND
This study attempted to replicate whether a bias in probabilistic reasoning, or 'jumping to conclusions'(JTC) bias is associated with being a sibling of a patient with schizophrenia spectrum disorder; and if so, whether this association is contingent on subthreshold delusional ideation.
METHODS
Data were derived from the EUGEI project, a 25-centre, 15-country effort to study psychosis spectrum disorder. The current analyses included 1261 patients with schizophrenia spectrum disorder, 1282 siblings of patients and 1525 healthy comparison subjects, recruited in Spain (five centres), Turkey (three centres) and Serbia (one centre). The beads task was used to assess JTC bias. Lifetime experience of delusional ideation and hallucinatory experiences was assessed using the Community Assessment of Psychic Experiences. General cognitive abilities were taken into account in the analyses.
RESULTS
JTC bias was positively associated not only with patient status but also with sibling status [adjusted relative risk (aRR) ratio : 4.23 CI 95% 3.46-5.17 for siblings and aRR: 5.07 CI 95% 4.13-6.23 for patients]. The association between JTC bias and sibling status was stronger in those with higher levels of delusional ideation (aRR interaction in siblings: 3.77 CI 95% 1.67-8.51, and in patients: 2.15 CI 95% 0.94-4.92). The association between JTC bias and sibling status was not stronger in those with higher levels of hallucinatory experiences.
CONCLUSIONS
These findings replicate earlier findings that JTC bias is associated with familial liability for psychosis and that this is contingent on the degree of delusional ideation but not hallucinations.

Identifiants

pubmed: 33046166
doi: 10.1017/S0033291720003578
pii: S0033291720003578
pmc: PMC9280279
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1777-1783

Subventions

Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G08005009
Pays : United Kingdom

Références

Q J Exp Psychol A. 1988 Nov;40(4):801-12
pubmed: 3212213
World Psychiatry. 2019 Feb;18(1):88-96
pubmed: 30600612
Cogn Neuropsychiatry. 2013 May;18(3):208-18
pubmed: 22758619
World Psychiatry. 2019 Jun;18(2):173-182
pubmed: 31059627
Schizophr Bull. 2015 Mar;41(2):400-10
pubmed: 25053650
Schizophr Bull. 2015 Sep;41(5):1183-91
pubmed: 25616503
Psychol Med. 2021 Mar;51(4):623-633
pubmed: 32327005
Schizophr Bull. 2011 Mar;37(2):324-33
pubmed: 19520745
J Abnorm Psychol. 2010 Feb;119(1):83-92
pubmed: 20141245
Br J Clin Psychol. 1999 Jun;38(2):113-54
pubmed: 10389596
BMC Psychiatry. 2016 Feb 27;16:51
pubmed: 26921116
J Abnorm Psychol. 2005 Aug;114(3):373-384
pubmed: 16117574
Schizophr Bull. 2006 Apr;32(2):341-51
pubmed: 16254066
Schizophr Bull. 2014 Jul;40(4):729-36
pubmed: 24860087
Schizophr Bull. 2010 Nov;36(6):1140-8
pubmed: 19429844
Acta Psychiatr Scand. 2006 Jul;114(1):55-61
pubmed: 16774662
PLoS One. 2015 Mar 20;10(3):e0121347
pubmed: 25793772
Behav Res Ther. 2007 Jun;45(6):1255-69
pubmed: 17052687
Cogn Neuropsychiatry. 2013;18(6):574-93
pubmed: 23167265
Clin Psychol Rev. 2016 Jun;46:151-67
pubmed: 27216559
Schizophr Res. 2008 Jul;102(1-3):254-60
pubmed: 18442898
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
J Exp Psychol. 1966 Sep;72(3):346-54
pubmed: 5968681
J Behav Ther Exp Psychiatry. 2017 Sep;56:106-112
pubmed: 27639287
Br J Psychiatry Suppl. 2007 Dec;51:s38-42
pubmed: 18055936
Schizophr Bull. 2011 Jul;37(4):850-60
pubmed: 20044595
Psychol Med. 2019 Aug;49(11):1799-1809
pubmed: 30160228
Psychol Med. 2011 Sep;41(9):1823-32
pubmed: 21275083
Schizophr Bull. 2016 May;42(3):652-65
pubmed: 26519952
Soc Psychiatry Psychiatr Epidemiol. 2014 Aug;49(8):1179-89
pubmed: 25005465
J Abnorm Psychol. 2012 Feb;121(1):129-139
pubmed: 21910515
Schizophr Bull. 2017 Mar 1;43(2):344-354
pubmed: 27169465
Schizophr Res. 2000 Dec 15;46(2-3):209-15
pubmed: 11120433

Auteurs

Cécile Henquet (C)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.

Jim van Os (J)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.
Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Department of Psychosis Studies, King's College London, Institute of Psychiatry, London, UK.

Lotta K Pries (LK)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.

Christian Rauschenberg (C)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.
Department of Public Mental Health, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.

Philippe Delespaul (P)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.

Gunter Kenis (G)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.

Jurjen J Luykx (JJ)

Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Department of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
GGNet Mental Health, Apeldoorn, The Netherlands.

Bochao D Lin (BD)

Department of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Alexander L Richards (AL)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.

Berna Akdede (B)

Department of Psychiatry, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.

Tolga Binbay (T)

Department of Psychiatry, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.

Vesile Altınyazar (V)

Department of Psychiatry, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey.

Berna Yalınçetin (B)

Department of Neuroscience, Health Sciences Institute, Dokuz Eylul University, Izmir, Turkey.

Güvem Gümüş-Akay (G)

Department of Physiology, School of Medicine, Ankara University, Ankara, Turkey.
Brain Research Center, Ankara University, Ankara, Turkey.

Burçin Cihan (B)

Department of Psychology, Middle East Technical University, Ankara, Turkey.

Haldun Soygür (H)

Turkish Federation of Schizophrenia Associations, Ankara, Turkey.

Halis Ulaş (H)

Department of Psychiatry, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey (Discharged by statutory degree No: 701 at 8th July of 2018, because of signing "Peace Petition").

Eylem S Cankurtaran (ES)

Güven Çayyolu Healthcare Campus, Ankara, Turkey.

Semra U Kaymak (SU)

Atatürk Research and Training Hospital Psychiatry Clinic, Ankara, Turkey.

Marina M Mihaljevic (MM)

Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Clinic for Psychiatry CCS, Belgrade, Serbia.

Sanja S Petrovic (SS)

Clinic for Psychiatry CCS, Belgrade, Serbia.

Tijana Mirjanic (T)

Special Hospital for Psychiatric Disorders Kovin, Kovin, Serbia.

Miguel Bernardo (M)

Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain.
Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.

Gisela Mezquida (G)

Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.

Silvia Amoretti (S)

Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain.
Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.

Julio Bobes (J)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
Department of Psychiatry, School of Medicine, University of Oviedo, Oviedo, Spain.
Mental Health Services of Principado de Asturias, Oviedo, Spain.

Pilar A Saiz (PA)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
Department of Psychiatry, School of Medicine, University of Oviedo, Oviedo, Spain.
Mental Health Services of Principado de Asturias, Oviedo, Spain.

Maria P García-Portilla (MP)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
Department of Psychiatry, School of Medicine, University of Oviedo, Oviedo, Spain.
Mental Health Services of Principado de Asturias, Oviedo, Spain.

Julio Sanjuan (J)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Psychiatry, Hospital Clínico Universitario de Valencia, School of Medicine, Universidad de Valencia, Valencia, Spain.

Eduardo J Aguilar (EJ)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Psychiatry, Hospital Clínico Universitario de Valencia, School of Medicine, Universidad de Valencia, Valencia, Spain.

Jose L Santos (JL)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Psychiatry, Hospital Virgen de la Luz, Cuenca, Spain.

Estela Jiménez-López (E)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Health and Social Research Center, Universidad de Castilla-La Mancha, Cuenca, Spain.

Manuel Arrojo (M)

Department of Psychiatry, Instituto de Investigación Sanitaria, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.

Angel Carracedo (A)

Grupo de Medicina Genómica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) Universidad de Santiago de Compostela, Santiago de Compostela, Spain.
Fundación Publica Galega de Medicina Xenómica (SERGAS), IDIS, Santiago de Compostela, Spain.

Gonzalo López (G)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain.

Javier González-Peñas (J)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain.

Mara Parellada (M)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain.

Nadja P Maric (NP)

Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Institute of Mental Health, Belgrade, Serbia.

Cem Atbaşoğlu (C)

Department of Psychiatry, School of Medicine, Ankara University, Ankara, Turkey.

Alp Ucok (A)

Department of Psychiatry, Faculty of Medicine, Istanbul University, Istanbul, Turkey.

Köksal Alptekin (K)

Department of Psychiatry, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey.
Department of Neuroscience, Health Sciences Institute, Dokuz Eylul University, Izmir, Turkey.

Meram C Saka (MC)

Department of Psychiatry, School of Medicine, Ankara University, Ankara, Turkey.

Celso Arango (C)

Biomedical Research Networking Centre in Mental Health (CIBERSAM), Spain.
Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain.

Michael O'Donovan (M)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, UK.

Bart P F Rutten (BPF)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.

Sinan Gülöksüz (S)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, the Netherlands.
Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH